Envista Holdings Corp
Health
Performance
4.1
Risk
Sell
Buy
Curious about the Scores? Learn more.

Envista Holdings Corp stock rating and score history

All changes in ratings, performance and outlook tracked over time.

24.01.2026
Risk creeping up. Stability not bulletproof anymore.
11.12.2025
Slight bounce. Could be noise – or a comeback brewing.
10.12.2025
Barely upright. Still chaotic, but slowly finding some balance.
20.08.2025
Pulse detected. Still fragile, but stabilizing.

Envista Holdings Corp stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Envista Holdings Corp do? Business model and key facts

Get the full picture of Envista Holdings Corp: what it builds, where it operates, and how it makes money.

Envista Holdings Corp Profile

Sector: Healthcare

Industry: Medical - Equipment & Services

Employees (FY): 12300

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

shop
Company facts
Paul A. Keel
CEO
12300
Employees worldwide
shop
Performance
11.34%
Last 12 months
-34.45%
Last 5 years
shop
Growth
$2,51B
Revenue year
$-1.118.600.000
Net income
shop
Valuation
$3,95B
Market Cap
-2.97
Price/Earnings Ratio

Stocks related to Envista Holdings Corp

Selected based on industry alignment and relative market positioning.

HIMS
Hims & Hers Health, Inc.
29.29
-3.27%
10.0
Sell
Buy
Hims & Hers Health, Inc.
LH
Labcorp Holdings Inc.
269.15
+0.66%
3.2
Sell
Buy
Labcorp Holdings Inc.
CON
Concentra Group Holdings Parent, Inc.
21.87
-1.40%
2.7
Sell
Buy
Concentra Group Holdings Parent, Inc.
NAKA
Nakamoto Inc.
0.38
+1.01%
8.9
Sell
Buy
Nakamoto Inc.

Envista Holdings Corp fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.